Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Total Liabilities (2020 - 2025)

Historic Total Liabilities for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to $131.3 million.

  • PROCEPT BioRobotics' Total Liabilities fell 124.81% to $131.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $131.3 million, marking a year-over-year decrease of 124.81%. This contributed to the annual value of $131.8 million for FY2024, which is 631.79% up from last year.
  • Latest data reveals that PROCEPT BioRobotics reported Total Liabilities of $131.3 million as of Q3 2025, which was down 124.81% from $127.3 million recorded in Q2 2025.
  • PROCEPT BioRobotics' 5-year Total Liabilities high stood at $206.3 million for Q2 2021, and its period low was $68.2 million during Q3 2021.
  • Its 5-year average for Total Liabilities is $119.1 million, with a median of $121.8 million in 2023.
  • Its Total Liabilities has fluctuated over the past 5 years, first tumbled by 6522.69% in 2022, then skyrocketed by 6333.44% in 2023.
  • PROCEPT BioRobotics' Total Liabilities (Quarter) stood at $69.9 million in 2021, then skyrocketed by 60.52% to $112.3 million in 2022, then increased by 10.43% to $124.0 million in 2023, then grew by 6.32% to $131.8 million in 2024, then fell by 0.4% to $131.3 million in 2025.
  • Its last three reported values are $131.3 million in Q3 2025, $127.3 million for Q2 2025, and $130.2 million during Q1 2025.